Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC320256 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8878 | High Similarity | NPC59314 |
0.8571 | High Similarity | NPC293163 |
0.8381 | Intermediate Similarity | NPC41958 |
0.7961 | Intermediate Similarity | NPC10466 |
0.7798 | Intermediate Similarity | NPC313547 |
0.7719 | Intermediate Similarity | NPC5707 |
0.7642 | Intermediate Similarity | NPC119133 |
0.7475 | Intermediate Similarity | NPC290449 |
0.7456 | Intermediate Similarity | NPC327579 |
0.7383 | Intermediate Similarity | NPC476562 |
0.7184 | Intermediate Similarity | NPC51000 |
0.7168 | Intermediate Similarity | NPC199790 |
0.7131 | Intermediate Similarity | NPC287876 |
0.7049 | Intermediate Similarity | NPC14330 |
0.6903 | Remote Similarity | NPC4837 |
0.6903 | Remote Similarity | NPC312187 |
0.6881 | Remote Similarity | NPC476561 |
0.688 | Remote Similarity | NPC324009 |
0.6838 | Remote Similarity | NPC240084 |
0.6825 | Remote Similarity | NPC319221 |
0.681 | Remote Similarity | NPC63433 |
0.6695 | Remote Similarity | NPC278549 |
0.6641 | Remote Similarity | NPC262926 |
0.6639 | Remote Similarity | NPC158847 |
0.6612 | Remote Similarity | NPC139776 |
0.6607 | Remote Similarity | NPC476099 |
0.6589 | Remote Similarity | NPC61198 |
0.646 | Remote Similarity | NPC476564 |
0.6457 | Remote Similarity | NPC246193 |
0.6452 | Remote Similarity | NPC248007 |
0.6343 | Remote Similarity | NPC186619 |
0.6316 | Remote Similarity | NPC18335 |
0.6303 | Remote Similarity | NPC327613 |
0.6293 | Remote Similarity | NPC75131 |
0.625 | Remote Similarity | NPC318590 |
0.625 | Remote Similarity | NPC211820 |
0.625 | Remote Similarity | NPC251233 |
0.622 | Remote Similarity | NPC144223 |
0.6204 | Remote Similarity | NPC317746 |
0.6204 | Remote Similarity | NPC274384 |
0.6204 | Remote Similarity | NPC177169 |
0.6204 | Remote Similarity | NPC89147 |
0.6159 | Remote Similarity | NPC64705 |
0.6159 | Remote Similarity | NPC232408 |
0.6116 | Remote Similarity | NPC148385 |
0.6107 | Remote Similarity | NPC57279 |
0.605 | Remote Similarity | NPC47936 |
0.6048 | Remote Similarity | NPC252603 |
0.6036 | Remote Similarity | NPC9639 |
0.597 | Remote Similarity | NPC320818 |
0.5942 | Remote Similarity | NPC8590 |
0.5882 | Remote Similarity | NPC30326 |
0.582 | Remote Similarity | NPC303899 |
0.5814 | Remote Similarity | NPC15566 |
0.5776 | Remote Similarity | NPC87981 |
0.5776 | Remote Similarity | NPC174114 |
0.576 | Remote Similarity | NPC189314 |
0.576 | Remote Similarity | NPC68938 |
0.5726 | Remote Similarity | NPC273327 |
0.5714 | Remote Similarity | NPC315642 |
0.5714 | Remote Similarity | NPC74306 |
0.5714 | Remote Similarity | NPC243319 |
0.5678 | Remote Similarity | NPC111132 |
0.5606 | Remote Similarity | NPC180462 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC320256 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8878 | High Similarity | NPD8837 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD9360 | Approved |
0.8 | Intermediate Similarity | NPD237 | Clinical (unspecified phase) |
0.7944 | Intermediate Similarity | NPD9375 | Discontinued |
0.7727 | Intermediate Similarity | NPD9374 | Approved |
0.7719 | Intermediate Similarity | NPD8830 | Phase 3 |
0.7642 | Intermediate Similarity | NPD9291 | Approved |
0.7545 | Intermediate Similarity | NPD9373 | Approved |
0.7456 | Intermediate Similarity | NPD307 | Approved |
0.7456 | Intermediate Similarity | NPD9607 | Approved |
0.7391 | Intermediate Similarity | NPD9409 | Discontinued |
0.7368 | Intermediate Similarity | NPD9606 | Approved |
0.72 | Intermediate Similarity | NPD9103 | Approved |
0.72 | Intermediate Similarity | NPD9102 | Approved |
0.7184 | Intermediate Similarity | NPD8838 | Approved |
0.7131 | Intermediate Similarity | NPD8829 | Clinical (unspecified phase) |
0.7097 | Intermediate Similarity | NPD209 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD515 | Phase 1 |
0.6909 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6825 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6746 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6746 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6641 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6589 | Remote Similarity | NPD1120 | Approved |
0.6589 | Remote Similarity | NPD1121 | Approved |
0.6589 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.6489 | Remote Similarity | NPD1808 | Phase 1 |
0.6452 | Remote Similarity | NPD9084 | Phase 2 |
0.6343 | Remote Similarity | NPD1430 | Approved |
0.6343 | Remote Similarity | NPD1431 | Approved |
0.6316 | Remote Similarity | NPD8836 | Approved |
0.6269 | Remote Similarity | NPD549 | Approved |
0.6202 | Remote Similarity | NPD9632 | Phase 3 |
0.6186 | Remote Similarity | NPD8954 | Approved |
0.6186 | Remote Similarity | NPD8955 | Approved |
0.6071 | Remote Similarity | NPD775 | Approved |
0.6048 | Remote Similarity | NPD9289 | Approved |
0.6048 | Remote Similarity | NPD9292 | Approved |
0.6048 | Remote Similarity | NPD9288 | Approved |
0.6048 | Remote Similarity | NPD76 | Approved |
0.5944 | Remote Similarity | NPD7842 | Phase 2 |
0.5944 | Remote Similarity | NPD3086 | Phase 3 |
0.5874 | Remote Similarity | NPD3085 | Phase 1 |
0.5854 | Remote Similarity | NPD9584 | Phase 2 |
0.5854 | Remote Similarity | NPD9086 | Approved |
0.5814 | Remote Similarity | NPD579 | Clinical (unspecified phase) |
0.5812 | Remote Similarity | NPD340 | Approved |
0.5812 | Remote Similarity | NPD341 | Approved |
0.576 | Remote Similarity | NPD8831 | Approved |
0.576 | Remote Similarity | NPD8833 | Approved |
0.5714 | Remote Similarity | NPD578 | Discontinued |
0.5714 | Remote Similarity | NPD582 | Approved |
0.5714 | Remote Similarity | NPD9081 | Clinical (unspecified phase) |
0.5705 | Remote Similarity | NPD4074 | Clinical (unspecified phase) |
0.5678 | Remote Similarity | NPD8861 | Approved |
0.5678 | Remote Similarity | NPD8862 | Approved |
0.5678 | Remote Similarity | NPD8859 | Approved |
0.5667 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5664 | Remote Similarity | NPD9101 | Discontinued |
0.5649 | Remote Similarity | NPD9408 | Phase 3 |
0.5615 | Remote Similarity | NPD798 | Discontinued |
0.5606 | Remote Similarity | NPD300 | Approved |
PubChem CID   | 65154 |
ChEMBL   | CHEMBL1328799 |
ZINC   |
Molecular Weight:   | 167.04 |
ALogP:   | -1.5667 |
MLogP:   | 1.24 |
XLogP:   | -0.966 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 117.38 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 5 |
# Rings:   | 2 |
# Heavy Atoms:   | 12 |